Skye Bioscience, Inc.
SKYE· Nasdaq
Filed May 13, 2015 · 10-Q · 43 days after period end · 0001557240-15-000300
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Net Income | -$910.23K | -$30.10K |
| EPS Diluted | -$0.06 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 13, 2015 · 43 d after period end